parkinson-disease

Documents about parkinson-disease

• Imaging Core Aim 2, and Udall Project 2 Aim 2#859185ClinicalTrials.gov
• Dysarthria Management for Minor Groups#861196ClinicalTrials.gov
• Is Trimethylamine N-oxide a Friend, Foe, or Hormetic Agent in Patients with Parkinson’s Disease: A Focused Review of One Microbial Metabolite#272153BYU ScholarsArchive
• Data Sheet 1_Clinicians’ views on a patient decision aid for deep brain stimulation in Parkinson’s disease.pdf#361736Figshare
• Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: The ORCHESTRA Study#642352Europe PMC
• Multicentre, randomised, single-blind, parallel group trial to compare the effectiveness of a Holter for Parkinson's symptoms against other clinical monitoring methods: Study protocol#325478Dipòsit Digital de la Universitat de Barcelona
• A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease#839502ClinicalTrials.gov
• Transcutaneous tibial nerve stimulation for overactive bladder symptoms in Parkinson’s disease: results from a phase II randomised control trial (STRIPE)#251987Spiral
• Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson’s disease#368667Repositorio Institucional UCA
• Temporal dynamics of cognitive functioning in people with Parkinson's disease#5525Europe PMC
• Genetic and Proteomic Investigation of the Smoking-Parkinson Disease Association#200191bioRxiv / medRxiv
• Pre-beta burst dynamics in Parkinson’s disease: distinguishing signal from artifact#203153PMC Full-Text (OAI)
• Nonmotor Symptoms in Parkinson's Disease: Neurophysiology Biomarkers and Neuromodulation Approaches.#218859NCBI PubMed Central
• Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations.#223036NCBI PubMed Central
• Patient-Reported Communication Decline Following Deep Brain Stimulation in Parkinson's Disease.#317928NCBI PubMed Central
• An N-acylphosphatidylethanolamine-LRRK2 axis controls lysosomal homeostasis in Parkinson s disease#329313bioRxiv / medRxiv
• EYE movement abnormalities in Parkinson's disease: optometric screening and rehabilitation.#330744NCBI PubMed Central
• Quantitative Gait Categorization in Parkinson's Disease with and without Freezing of Gait#363408bioRxiv / medRxiv
• Modelling Parkinson’s Disease pathology using MITF mutant mice#369423ADA University of Tartu Library
• Creative thinking in Parkinson's disease: A systematic review and meta-analysis.#375170NCBI PubMed Central
• Metabolomic signatures for diagnosis and clinical severity in Parkinson's disease.#380803NCBI PubMed Central
• Association of Levels of Physical Activity With Risk of Parkinson Disease#383868CiNii
• When rhythm guides speech production: insights from Parkinson’s disease and spinocerebellar ataxia#398710HAL (France)
• Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease.#422956NCBI PubMed Central
• Identifying Blood Proteomic Markers of Parkinson's Disease Dementia Using High-Throughput Approaches#438521bioRxiv / medRxiv
• Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease risk.#659724NCBI PubMed Central
• Percept Transitions in FOG and PD#805779ClinicalTrials.gov
• PK Study of WD-1603 in Healthy Subjects#826974ClinicalTrials.gov
• El ejercicio físico mejora la calidad de vida de los pacientes con la enfermedad de Parkinson. Revisión Sistemática: Physical exercise improves the quality of life of patients with Parkinson's disease. Systematic review#189464Dialnet
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson's disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies#123333Europe PMC
• Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease#825990ClinicalTrials.gov
• Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes#852944ClinicalTrials.gov
• Using explainable AI to identify disease-relevant and deep brain stimulation treatment-sensitive gait features in Parkinson's disease.#275523NCBI PubMed Central
• Biological Sample Collection for Research and Biobanking#279656ClinicalTrials.gov
• Association of Cardiac Autonomic Dysfunction and Cognitive Impairment With Disease Severity in Parkinson's Disease: A Cross-Sectional Study.#385222NCBI PubMed Central
• Effects of mindfulness-based exercise on Parkinson's disease and Alzheimer's disease: a systematic review and meta-analysis.#455065NCBI PubMed Central
• Antemortem α-Synuclein levels from neuron-derived extracellular vesicles identify Lewy Body pathology in Parkinson's Disease and Alzheimer Disease#640151bioRxiv / medRxiv
• Deciphering the Impact of Exposures From the Gut Microbiome-derived Molecular Complex in Human Health and Disease#851493ClinicalTrials.gov
• Subcutaneous foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson’s disease (aPD): societal cost impact analysis for the UK, France, Germany, Spain, and Canada#384363Figshare
• Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease#808010ClinicalTrials.gov
• Italian Translation and Validation of the Non-Motor Fluctuation Assessment (NoMoFA) Questionnaire: an Observational, Multicentric, Cross-sectional, 6-months Duration Study on 200 Consecutive Parkinson's Disease Patients.#827229ClinicalTrials.gov
• A Randomised Controlled Trial (RCT) to Evaluate Use of an Individual Auditory Cueing Device's (IACD's) on Freezing and Gait in People With Parkinson's Disease (PD)#837393ClinicalTrials.gov
• Monoaminergic Networks of Cognitive and Behavioral Symptoms in Early Parkinson's Disease.#1345NCBI PubMed Central
• Striatal Dopamine Transporter and Rest Tremor in Parkinson Disease: A Clinical Validation#5590Europe PMC
• Short term heart rate variability is preserved in Parkinson's disease under atomoxetine#13891bioRxiv / medRxiv
• StimVision: smartphone video kinematics to optimize DBS programming in Parkinson's disease#125803Europe PMC
• Predicting long term clinical outcomes in Parkinson's Disease using short term rating scales#138696bioRxiv / medRxiv
• Toward clinical implementation of a metabolic blood biomarker for Parkinson's disease differential diagnosis#158286bioRxiv / medRxiv
• Comparing Stakeholders' Perspectives on Parkinson Disease Management and Digital Technologies: Exploratory International Survey.#213852NCBI PubMed Central
• Cognitive effects of STN-DBS on mental rotation performance in Parkinson's disease.#213877NCBI PubMed Central